Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
P 1 (2)

Trial Status

Unknown1
Active Not Recruiting1

Clinical Trials (2)

Showing 2 of 2 trials
NCT05551858Phase 1Active Not Recruiting

Role of a CCK Receptor Antagonist Proglumide in Management of Chronic Pancreatitis

NCT05641233Phase 1Unknown

Preoperative Radiotherapy in Patients at High Risk of Postoperative Pancreatic Fistula After Pancreatoduodenectomy

Showing all 2 trials

Research Network

Activity Timeline